Similar articles

• A single center experience with "low-dose" cyclosporine in cadaveric renal transplantation.

  Fries D, Hiesse C, Charpentier B, Lantz O, Bensadoun H, Benoit G. Fries D, et al. Clin Transpl. 1988:115-29. Clin Transpl. 1988. PMID: 3154465 Clinical Trial. No abstract available.
• [4-way immunosuppression in pre-sensitized recipients of allogenic cadaver kidney transplants].

  Oesterwitz H, May G, Müller P, Strobelt V, Seeger W, Seibt F, Horlbeck R, Hansen C. Oesterwitz H, et al. Z Urol Nephrol. 1990 Jan;83(1):1-8. Z Urol Nephrol. 1990. PMID: 2184625 German.
• Cadaver kidney transplantation: a retrospective comparison of two immunosuppressive regimens.

  Dandavino R, Barcelo R, Beaudry C, Cardinal J, Carriere S, Friborg J, Houde M, Ouimet D, Bastien E, Girard R, Laplante L. Dandavino R, et al. Transplant Proc. 1982 Dec;14(4):635-9. Transplant Proc. 1982. PMID: 6762720 No abstract available.
• Control of rejection of transplanted organs.

  Keown PA, Stiller CR. Keown PA, et al. Adv Intern Med. 1986;31:17-46. Adv Intern Med. 1986. PMID: 3511616 Review. No abstract available.
• Nursing implications of immunosuppression in transplantation.

  Shaefer M, Williams L. Shaefer M, et al. Nurs Clin North Am. 1991 Jun;26(2):291-314. Nurs Clin North Am. 1991. PMID: 1904575 Review.